NDC 66215-628

UPTRAVI Titration Pack

Selexipag

UPTRAVI Titration Pack is a Kit in the Human Prescription Drug category. It is labeled and distributed by Actelion Pharmaceuticals Us, Inc.. The primary component is .

Product ID66215-628_32a13445-38fd-4dcd-b2e1-e84b7c11d4b6
NDC66215-628
Product TypeHuman Prescription Drug
Proprietary NameUPTRAVI Titration Pack
Generic NameSelexipag
Dosage FormKit
Marketing Start Date2015-12-21
Marketing CategoryNDA / NDA
Application NumberNDA207947
Labeler NameActelion Pharmaceuticals US, Inc.
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 66215-628-20

1 KIT in 1 CARTON (66215-628-20) * 1 BOTTLE in 1 CARTON > 140 TABLET, COATED in 1 BOTTLE * 1 BOTTLE in 1 CARTON > 60 TABLET, COATED in 1 BOTTLE
Marketing Start Date2015-12-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 66215-628-20 [66215062820]

UPTRAVI Titration Pack KIT
Marketing CategoryNDA
Application NumberNDA207947
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-12-21

Drug Details

OpenFDA Data

SPL SET ID:a7a23b87-f892-4e2c-8e2e-ebf841220f90
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1729007
  • 1729063
  • 1729059
  • 1729065
  • 1729075
  • 1729061
  • 1729055
  • 1729057
  • 1729051
  • 1729047
  • 1729053
  • 1729045
  • 1729029
  • 1729013
  • 1729027
  • 1729033
  • 1729031
  • 1729076

    • NDC Crossover Matching brand name "UPTRAVI Titration Pack" or generic name "Selexipag"

    NDCBrand NameGeneric Name
    66215-628UPTRAVI Titration PackUPTRAVI Titration Pack
    66215-602UPTRAVISelexipag
    66215-604UPTRAVISelexipag
    66215-606UPTRAVISelexipag
    66215-608UPTRAVISelexipag
    66215-610UPTRAVISelexipag
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.